Sinotherapeutics, Inc. Class ASSE: 688247

"SINOTHERAPEUTICS INC."Announcement on Abnormal Fluctuations in Stock Trading

Jul 3, 2026 · Issued by Sinotherapeutics, Inc. Class A via Shanghai Stock Exchange

Announcement on Abnormal Fluctuations in Stock Trading

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Sinotherapeutics, Inc. Class A

Announcement on Implementation of Dividend Distribution for 2025Jun 22
Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Shareholding ReductionJun 11
Senior Management Member" -- Announcement on Completing Term Change and Election of the Board of Directors and Appointing Senior Management Members and Securities Affairs Representative, as well as Departure of Core Technical PersonnelMay 29
Announcement on Voluntary Disclosure of Obtaining the Colombian INVIMA Approval for Bupropion Hydrochloride Extended-release TabletsMay 26

All Sinotherapeutics, Inc. Class A news releases